What this study is
The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors.
What's being tested
- FoodiiS plus Culinary Essentials Food Delivery
Intervention · DIETARY SUPPLEMENT
The FoodiiS intervention will include videos, recipes, and other online healthy eating content adapted from previously developed materials.
- Culinary Essentials Food Delivery Only
Intervention · DIETARY SUPPLEMENT
To support participants in effectively learning the healthy cooking strategies and mitigate access issues, investigators will provide participating families two home food deliveries of non-perishable culinary ingredients that are related to HCI practices including whole grain versions of common products (brown rice, whole wheat flour), healthier cooking oils (olive and canola), and a core selection of herbs and spices, among other goods.
- Waitlist control
Intervention · DIETARY SUPPLEMENT
The control group will receive no intervention until after T1. After the T1 data collection time point, the control group will receive all FoodiiS intervention materials.
Study details
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Pediatric Cancer
- Enrolling
- 21 people
- Starts
- 2026-12-30
- Est. completion
- 2029-07-01
- Design
- Open-label, randomized, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers AcceptedYou may qualify if
- Parents/guardians of school-aged (5-12 years) pediatric cancer survivors.
- Have children that are within five years of having completed active treatment.
- Self-report having internet access.
- Self-report as being able to speak and read English.
- Willing to complete study assessments.
You can't join if
- Parents of pediatric cancer survivors over 12 years of age.
- Unwilling or unable to complete study assessments.
- Self-report to not speak English.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openThe University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
- Margaret Raber, DRPH · Contactmpraber@mdanderson.org
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID 2025-1327
Principal investigator
Marget Raber, DRPH
M.D. Anderson Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.